VACCINES SUMMARY
SPECIAL
NAME STRAIN
PFIZER
mRNA (BNT162b2) VACCINE
MODERNA
mRNA (mRNA-1273) VACCINE
PEGYLATED LIPID NANOPARTICLE
DELIVERY SYSTEM
COVAXIN
KILLED BB152 (WHOLE VIRUS)
VACCINE
NIV-2020-770 STRAIN
BBV - 154
COVID
COVISHIELD (ASTRAZENECA)
RECOMBINANT ChAdOx1 nCoV-19
(VIRAL VECTOR) BASED
MONOVALENT
2 DOSES; 12-16 WEEKS APART
CHIMPANZEE ADENOVIRUS
DERIVED
NOVAVAX
SPIKE PROTEIN NVX-CoV2373
SUBUNIT VACCINE
SPUTNIK V
(VIRAL VECTOR) BASED
ADENOVIRUS DERIVED
OKA STRAIN
VARICELLA IAP - 2 DOSES (12-15 Mo, 18-24 Mo)
VARIVAX - LIVE ATTENUATED
ADULTS - 2 DOSES; 4 WEEKS APART
HERPES ZOSTER ZOSTAVAX - LIVE ATTENUATED
EDMONSTON ZAGREB STRAIN
(AEROSOLIZED)
MEASLES SCHWARZ & MORATEN (HEAT
STABLE) GIVEN WITHIN 3 DAYS OF CONTACT
LIVE ATTENUATED
JERYL LYNN STRAIN
MUMPS
LIVE ATTENUATED
2 DOSES; 4-6 WEEKS APART
DOSE IMMUNITY CONSTITUENTS ADVERSE EFFECTS MAX AGE
CONTRAINDICATIONS
0.3 ML INTRAMUSCULAR USED WITHIN 6 HRS AGE < 16 YRS
U/ARM COLD/FREEZE SENSITIVE NORMAL SALINE BUFFER PREGNANCY
2 DOSES; 3 WEEKS APART STORED AT -80 - -60 DEGREES LACTATION
0.5 ML INTRAMUSCULAR USED WITHIN 6 HRS AGE < 18 YRS
FACIAL SWELLING
U/ARM COLD/FREEZE SENSITIVE PREGNANCY
BELLS PALSY
2 DOSES; 4 WEEKS APART STORED AT +2 - +8 DEGREES LACTATION
0.5 ML INTRAMUSCULAR USED WITHIN 6 HRS INTERACTS WITH
U/ARM COLD/FREEZE SENSITIVE CHLOROQUINE &
2 DOSES; 4 WEEKS APART STORED AT +2 - +8 DEGREES CORTICOSTEROIDS
NASAL VACCINE
AGE < 18 YRS
0.5 ML INTRAMUSCULAR USED WITHIN 6 HRS
IMMUNOCOMPROMISED
U/ARM COLD/FREEZE SENSITIVE
THROMBOCYTOPENIA
STORED AT +2 - +8 DEGREES
PREGNANCY
LACTATION
0.5 ML INTRAMUSCULAR USED WITHIN 6 HRS
U/ARM COLD/FREEZE SENSITIVE
2 DOSES; 3 WEEKS APART STORED AT +2 - +8 DEGREES
0.5 ML INTRAMUSCULAR USED WITHIN 6 HRS
U/ARM COLD/FREEZE SENSITIVE
2 DOSES; 3 WEEKS APART STORED AT +2 - +8 DEGREES
0.5 ML; SUBCUTANEOUS
IMMUNITY FOR 10 YEARS
NEOMYCIN
HEAT SENSITIVE
0.65 ML; SUBCUTANEOUS
SINGLE DOSE
USED WITHIN 4 HRS FEBRILE SEIZURES,
0.5 ML; SUBCUTANEOUS DISTILLED WATER BUFFER
HEAT SENSITIVE THROMBOCYTOPENIA,
RIGHT U/ARM MgSO4 STABILIZER 5 YRS
LIGHT SENSITIVE SSPE
NEOMYCIN/ERYTHROMYCIN
IMMUNITY DEVELOPS AFTER 10 DAYS TOXIC SHOCK SYNDROME
0.5 ML; SUBCUTANEOUS
RIGHT U/ARM NEOMYCIN EGG ALLERGY
Compiled by
Dr. Bhargav Shreeram. G
 VACCINES SUMMARY

0.5 ML; SUBCUTANEOUS

RA 27/3 STRAIN IMMUNITY DEVELOPS AFTER 14 DAYS;
RUBELLA RIGHT U/ARM NEOMYCIN INFANTS & PREGNANTS 5 YRS
LIVE ATTENUATED LASTS TILL ADULTHOOD
2 DOSES
MR NIS - 2 DOSES (9-12 Mo, 16-24 Mo) 15 YRS
MMR IAP - 3 DOSES (9 Mo, 15 Mo, 4-6 YRS)
FLUZONE; FLUARIX; FLUBLOK
KILLED
EGG BASED
GUILLAIN BARRE
TRIVALENT (MICHIGAN + 0.5 ML INTRAMUSCULAR / FORMALDEHYDE INACTIVATED
SYNDROME,
COLORADO + SWITZERLAND) 0.1 ML INTRADERMAL (FLUZONE ONLY) THIOMERSAL PRESERVATIVE EGG ALLERGY
OCULORESPIRATORY
QUADRIVALENT (TRIVALENT + IAP - 6 DOSES (6 Mo,7Mo, 2,3,4,5 YRS) NEOMYCIN/GENTAMICIN
INFLUENZA SYNDROME
PHUKET)
NON-EGG BASED
SINGAPORE
AGE >50 YRS
FLAV (FLU LIVE ATTENUATED
NASAL SPRAY IMMUNOCOMPROMISED
VACCINE)
PREGNANCY
LIVE ATTENUATED 0.5 ML SUBCUTANEOUS
H2 / LA1 STRAIN IAP - SINGLE DOSES (12 Mo)
HEPATITIS A CHILDREN - 0.5 ML; ADULTS - 1 ML
HAVRIX - KILLED (M/C) IMMUNITY DEVELOPS AFTER 4 WKS;
INTRAMUSCULAR FORMALDEHYDE INACTIVATED AGE< 1 YR
MONOVALENT IMMUNITY LASTS TILL 20 YRS
IAP - 2 DOSES (12, 18 Mo)
INTRAMUSCULAR
LEFT A/L THIGH COLD/FREEZE SENSITIVE FORMALDEHYDE INACTIVATED DAY-1 (ZERO DOSE); 1
HEPATITIS B RECOMBINANT KILLED SUBUNIT NIS/IAP - CHILDREN - 4 DOSES (0.5ML; NO EFFECT ON CARRIERS ASO4 ADJUVANT YR (REMAINING
BIRTH,6,10,14 WKS) IMMUNITY LASTS TILL 15 YEARS THIOMERSAL PRESERVATIVE DOSES)
ADULT - 3 DOSES (1 ML; 0,1,6 Mo)
USED WITHIN 1/2 HR AGE <9Mo
17-D; ASIBI STRAIN DERIVATIVE 0.5 ML SUBCUTANEOUS IMMUNITY DEVELOPS AFTER 10 DAYS; EGG ALLERGY VACCINE ASSOCIATED
YELLOW FEVER
LIVE ATTENUATED SINGLE DOSE IMMUNITY LASTS LIFETIME PREGNANCY VISCEROTROPIC DISEASE
HEAT SENSITIVE IMMUNOCOMPROMISED
SUBCUTANEOUS
CHILDREN (<15YRS) - 0.5 ML; ADULTS
KYASANUR FOREST
KILLED (>15 YRS) - 1 ML FORMALDEHYDE INACTIVATED
DISEASE
2 DOSES WITHIN 6-9 Mo; ANNUAL
BOOSTER DOSE FOR 5-6 YRS

Compiled by
Dr. Bhargav Shreeram. G
 VACCINES SUMMARY

KILLED
RABIVAC - HUMAN DIPLOID CELL MODIFIED ESSEN REGIMEN - 5 DOSES;
VACCINE - PITMAN MOORE STRAIN ONE SITE (DAY 0,3,7,14,28)
RABIPUR - PURIFIED CHICK INTRAMUSCULAR
RABIES THIOMERSAL PRESERVATIVE
EMBRYO CELL VACCINE - FLURY THAI RED CROSS SCHEDULE - 4 DOSES;
STRAIN TWO SITES (DAY 0,3,7,28) 0.1 ML
VERORAB - PURIFIED VERO CELL INTRADERMAL
VACCINE - WISTAR STRAIN

0.5ML SUBCUTANEOUS
LIVE ATTENUATED - SA-14-14-2 LEFT U/ARM USED WITHIN 2 HRS
PHOSPHATE BUFFER 15 YRS
(M/C) NIS - CHILDREN (<15YRS) - 2 DOSES HEAT SENSITIVE
(9Mo, 16-24Mo)
VERO CELL CULTURE DERIVED -
SUBCUTANEOUS
BEIJING, NAKAYAMA STRAIN
ADULT (>15YRS) - 3 DOSES (DAY 0,7,28)
JAPANESE KILLED
ENCEPHALITIS INTRAMUSCULAR
JEEV, IXIARO (KILLED)
1-3 YRS (0.25ML ON DAY 0,28);
VERO CELL CULTURE DERIVED
IAP - 2 DOSES (12,13 Mo)
FROM SA-14-14-2
>3YRS/ADULTS (0.5 ML ON DAY 0,28);
JENVAC (KILLED)
0.5 ML INTRAMUSCULAR
VERO CELL CULTURE DERIVED
SINGLE DOSE
FROM 821564-XY INDIAN STRAIN
RECOMBINANT ADENO
ASSOCIATED VIRUS (Raav)
ALVAC-HIV
1 ML INTRAMUSCULAR Gp 120 CORE PROTEIN ;
RECOMBINANT CANARY POX
4 DOSES (0,4,12,24 WKS) GAG & PROTEASE
VECTOR BASED
AIDS
AIDSVAX 1 ML INTRAMUSCULAR
Gp 120 CORE PROTEIN
BIVALENT SUBUNIT VACCINE 2 BOOSTERS (12,24 WKS)
0.5 ML SUBCUTANEOUS
IMVANEX - MODIFIED VACCINIA
U/ARM GENTAMICIN GENTAMICIN ALLERGY
ANKARA (MVA)
2 DOSES; 4 WEEKS APART

P2 - VACCINE DERIVED
USEFUL IN EPIDEMICS
2 DROPS ORAL POLIO VIRUS DAY-15 (ZERO DOSE);
SABIN OPV (LIVE ATTENUATED) HERD IMMUNITY SEEN
NIS - 3 DOSES (BIRTH, 6,10,14 WKS MgCl2 / SUCROSE STABILIZER P3 (MOST IMMUNOGENIC)- 5 YRS (REMAINING
BIVALENT (P1,P3) MUCOSAL IMMUNITY SEEN
BOOSTER - 16-24Mo) VACCINE ASSOCIATED DOSES)
HEAT SENSITIVE
PARALYTIC POLIO
POLIO

Compiled by
Dr. Bhargav Shreeram. G
 VACCINES SUMMARY

0.1 ML INTRADERMAL
NOT USEFUL IN EPIDEMICS
RIGHT A/L THIGH FORMALDEHYDE INACTIVATED
SALK fractionated IPV (KILLED) NO HERD IMMUNITY
NIS - 2 DOSES (6, 14 WKS) PHENOXYETHANOL PRESERVATIVE 1 YR
TRIVALENT (P1,P2,P3) NO MUCOSAL IMMUNITY
IAP - 3 DOSES (6,10,14 WKS); NEOMYCIN + STREPTOMYCIN
HEAT STABLE
2 BOOSTER (16-18 Mo, 4-6 YRS)
ROTAVAC (M/C)
NIS - 5 DROPS ORAL USED WITHIN 4-6 HRS
LIVE ATTENUATED AGE >6Mo INTUSSUSCEPTION 1 YR
3 DOSES (6,10,14 WKS) HEAT SENSITIVE
ORV116E MONOVALENT STRAIN
ROTATEQ
LIVE ATTENUATED 2 ML ORAL
ROTA AGE >8Mo
PENTAVALENT BOVINE-HUMAN 3 DOSES (2,4,6 Mo)
ASSORTED
ROTARIX
1 ML ORAL
LIVE ATTENUATED AGE >8Mo
2 DOSES (2,4 Mo)
RIX4414 MONOVALENT STRAIN
DENGVAXIA
0.5 ML SUBCUTANEOUS
DENGUE LIVE ATTENUATED AGE <9 YRS; >45 YRS
3 DOSES (0,6,12 Mo)
CYD-TDV TETRAVALENT STRAIN
0.5 ML INTRAMUSCULAR
U/ARM
CERVARIX
IAP (9-14 YRS) RECOMBINANT L1 CAPSID PROTEIN
BIVALENT (16,18)
2 DOSES; 6 Mo APART ASO4 ADJUVANT
RECOMBINANT
>15 YRS / IMMUNOCOMPROMISED
3 DOSES (0,1,6 Mo)
0.5 ML INTRAMUSCULAR
U/ARM
HPV GARDASIL
IAP (9-14 YRS) RECOMBINANT L1 CAPSID PROTEIN
QUADRIVALENT (6,11,16,18)
2 DOSES; 6 Mo APART ALUM ADJUVANT
RECOMBINANT
>15 YRS / IMMUNOCOMPROMISED
3 DOSES (0,2,6 Mo)
GARDASIL-9
0.5 ML INTRAMUSCULAR
NONAVALENT RECOMBINANT L1 CAPSID PROTEIN
U/ARM
(6,11,16,18,31,33,45,52,58) ALUM ADJUVANT
3 DOSES (0,2,6 Mo)
RECOMBINANT
FSME-IMMUN FORMALDEHYDE INACTIVATED
KILLED INTRAMUSCULAR ALUM ADJUVANT
TICK BORNE NEUDORFL STRAIN CHILDREN - 0.25 ML; ADULTS - 0.5 ML HUMAN ALBUMIN STABILIZER
AGE <1 YR
ENCEPHALITIS ENCEPUR 3 DOSES (1st & 2nd - 3 Mo APART; 2nd
KILLED & 3rd - 12 Mo APART) SUCROSE STABILIZER
K 23 STRAIN

Compiled by
Dr. Bhargav Shreeram. G
 VACCINES SUMMARY

MOSQUIRIX - RTSS/ASO1
PRE-ERYTHROCYTIC HYBRID 0.5 ML INTRAMUSCULAR
FALCIPARUM
RECOMBINANT PROTEIN VACCINE U/ARM ASO1 ADJUVANT
MALARIA
(P.falciparum CIRCUMSPOROZOITE 3 DOSES (0,1,2 Mo); BOOSTER AT 18 Mo
PROTEIN) WITH FREE HBsAg

ALUM ADJUVANT CRY, HYPOTENSIVE

PARK WILLIAM STRAIN
DIPHTHERIA THIOMERSAL PRESERVATIVE HYPORESPONSIVE EPISODE,
TOXOID
NEOMYCIN SEIZURES
NEUROLOGIC DEFICITS;
WHOLE CELL - LESS EFFICACY
PERTUSSIS TOXOID HIGHER FOR WHOLE CELL
ACELLULAR - HIGH EFFICACY
VACCINE
0.5 ML INTRAMUSCULAR
RIGHT U/ARM
NO HERD IMMUNITY FORMALDEHYDE INACTIVATED
TETANUS TETANUS TOXOID VACCINE NIS - CHILDREN - 2 DOSES (10, 16 YRS) BRACHIAL NEURITIS
COLD/FREEZE SENSITIVE ALUM ADJUVANT
PREGNANT - 2 DOSES; 4 WEEKS APART
ADULTS - 2 DOSES; 6-8 WEEKS APART
0.5 ML INTRAMUSCULAR
BioHib PRP CAPSULAR
HEMOPHILUS U/ARM
POLYSACCHARIDE VACCINE COLD/FREEZE SENSITIVE 1 YR
INFLUENZA IAP - 3 DOSES (6,10,14 WKS); 1
CONJUGATED TO TETANUS TOXOID
BOOSTER (16-18 Mo)
0.5 ML INTRAMUSCULAR
LEFT A/L THIGH
DPT NIS - 2 BOOSTERS (16-24 Mo, 5-6 YRS) COLD/FREEZE SENSITIVE 7 YRS
IAP - 3 DOSES (6,10,14 WKS); 2 IMMUNOCOMPROMISED
BOOSTERS (16-18 Mo, 4-6 YRS) NEUROLOGIC DEFICITS
0.5 ML INTRAMUSCULAR
PENTAVALENT DwPT + HepB + HiB LEFT A/L THIGH COLD/FREEZE SENSITIVE 1 YR
NIS - 3 DOSES (6,10,14 WKS)
3 DOSES (2,4,6 Mo) HIGHER DOSE OF DIPHTHERIA &
DTaP AGE <7 YRS COLD/FREEZE SENSITIVE
2 BOOSTERS (15-18 Mo, 4-6 YRS) PERTUSSIS TOXOIDS GIVEN IN
IAP - SINGLE DOSE OF TDaP AT 10 YRS LESSER DOSE OF DIPHTHERIA & CONTRAINDICATED
TdaP AGE 10-65 YRS COLD/FREEZE SENSITIVE
CATCH UP DOSE OF TDaP/TD EVERY 10 PERTUSSIS TOXOIDS INDIVIDUALS OF DPT
Td AGE 7-9 YRS; >65 YRS YEARS COLD/FREEZE SENSITIVE NO PERTUSSIS COMPONENT
WHOLE CELL RECOMBINANT VACCINE
DUKORAL 3 ML ORAL TAKEN WITH
WITH TOXIN-B SUBUNIT AGE<2 YRS
KILLED 2 DOSES; 1 WEEK APART BICARBONATE/GASTRIC BUFFER
IMMUNITY LASTS TILL 2 YRS
NO TOXIN-B SUBUNIT
CHOLERA SHANCHOL / mORCVAX 1.5 ML ORAL
IMMUNITY DEVELOPS AFTER 14 DAYS NO BUFFER REQUIRED AGE <1 YR
KILLED IAP - 2 DOSES (12,13 Mo)
IMMUNITY LASTS TILL 3 YRS

Compiled by
Dr. Bhargav Shreeram. G
 VACCINES SUMMARY

EUVICHOL 1.5 ML ORAL MORE STABLE & EFFICACIOUS

KILLED 2 DOSES; 2 WEEKS APART IMMUNITY LASTS TILL 3 YRS
AGE< 5YRS
TYPHORAL / Typhi 21a 1 CAPSULE ORAL ACUTE FEBRILE ILLNESS
IMMUNITY DEVELOPS AFTER 7 DAYS
LIVE ATTENUATED 3 DOSES (DAY 1,3,5) ACUTE INTESTINAL
TYPHOID MANIFESTATIONS
Typbar / Vi POLYSACCHARIDE 0.5 ML SUBCUTANEOUS /
AGE< 2YRS
VACCINE CONJUGATED TO INTRAMUSCULAR IMMUNITY DEVELOPS AFTER 7 DAYS PHENOL PRESERVATIVE
ALONG WITH PROGUANIL
TETANUS TOXOID IAP - SINGLE DOSE (6 Mo)
SOKHEY MODIFIED HAFFKINE SUBCUTANEOUS
VACCINE 2 DOSES (0.5ML ON DAY 0; 1ML ON DAY NOT USEFUL IN OUTBREAKS
KILLED 14)
PLAQUE
INTRAMUSCULAR
AMERICAN MADE VACCINE FORMALDEHYDE INACTIVATED
3 DOSES (FIRST DOSE - 1ML; 0.2 ML AT
KILLED PHENOL PRESERVATIVE
1,6 Mo)
0.1 ML INTRADERMAL USED WITHIN 4 HRS LOCAL ABSCESS
LIVE ATTENUATED 1 YR (DIRECT BCG);
BCG LEFT U/ARM HEAT SENSITIVE NORMAL SALINE BUFFER SUPPURATIVE
DANISH 1331 STRAIN 5 YRS (INDIRECT BCG)
NIS/IAP - SINGLE DOSE (AT BIRTH) LIGHT SENSITIVE LYMPHADENITIS
0.1 ML INTRADERMAL
MYCOBACTERIUM INDICUS PRAII
LEPROSY DIVIDED OVER BOTH ARMS IMMUNITY LASTS TILL 8 YRS
KILLED VACCINE
2 DOSES; 6 Mo APART
0.5 ML INTRAMUSCULAR
U/ARM
PREVNAR / PCV13 NIS - 2 DOSES (6,14 WKS); 1 BOOSTER (9
COLD/FREEZE SENSITIVE ALUM ADJUVANT 1YR
CONJUGATED Mo)
PNEUMOCOCCAL IAP - 3 DOSES (6,10,14 WKS); 1
BOOSTER (15 Mo)
PNEUMOVAX / PPSV23
0.5 ML INTRAMUSCULAR/
POLYSACCHARIDE IMMUNITY LASTS TILL 5 YRS ALUM ADJUVANT AGE<2 YRS
SUBCUTANEOUS; SINGLE DOSE

QUADRIVALENT MCV-4 0.5 ML INTRAMUSCULAR

ALUM ADJUVANT MAXIMUM CHANCES OF
MENINGOCOCCAL (A,C,W135,Y) IAP - 2 DOSES (9,12 Mo);
THIOMERSAL PRESERVATIVE ANAPHYLAXIS
CONJUGATED 1 BOOSTER (2-3 YEARS)

Compiled by
Dr. Bhargav Shreeram. G
VACCINES SUMMARY

Compiled by
Dr. Bhargav Shreeram. G
VACCINES SUMMARY

Compiled by
Dr. Bhargav Shreeram. G
VACCINES SUMMARY

Compiled by
Dr. Bhargav Shreeram. G